BSA stands for body surface area, a measurement of the total outer surface of the human body expressed in square meters (m²). It matters most in medicine, where it serves as a more reliable guide than body weight alone for calculating drug doses, estimating kidney function, and assessing burn severity. The average adult BSA is roughly 1.76 m², with typical values around 1.66 m² for women and 1.87 m² for men.
Why BSA Is Used Instead of Weight
Body weight seems like the obvious way to scale a medication dose, but it has a significant flaw: two people who weigh the same can have very different metabolic rates, organ sizes, and fluid volumes depending on their height, build, and body composition. BSA tracks more closely with the body’s metabolic rate, heat loss, blood volume, and the amount of fluid sitting outside cells. For drugs that distribute through those fluid compartments, dosing by surface area produces more consistent levels in the bloodstream than dosing by weight.
This distinction becomes especially important for powerful medications where the margin between an effective dose and a toxic one is narrow. Cancer chemotherapy is the classic example. When researchers compared drug doses across species, from mice to humans, the effective dose per unit of surface area stayed remarkably consistent, while the dose per kilogram of body weight varied widely. That finding, published by the American Association for Cancer Research, cemented BSA as the standard for cytotoxic drug dosing and it remains so today.
How BSA Is Calculated
You can’t easily measure someone’s skin surface directly, so clinicians rely on formulas that estimate BSA from height and weight. Three formulas dominate clinical practice:
- Du Bois and Du Bois (1916): The oldest and most widely used. It multiplies weight in kilograms (raised to the power of 0.425) by height in centimeters (raised to 0.725), then by a constant. It remains a cornerstone of medical practice despite being over a century old.
- Haycock (1978): Developed with pediatric patients in mind, using slightly different exponents for weight and height.
- Mosteller (1987): The simplest to calculate. You multiply height in centimeters by weight in kilograms, divide by 3,600, and take the square root. Its ease of use makes it popular for quick bedside estimates.
All three formulas produce similar results for adults of average build. Differences emerge at the extremes, particularly in very small children or people with obesity, where the choice of formula can meaningfully change the number.
Drug Dosing in Cancer Treatment
Oncology is where BSA has its biggest day-to-day impact. Chemotherapy drugs are almost universally dosed in milligrams per square meter of body surface area. The goal is to deliver enough of the drug to kill cancer cells while keeping side effects within a tolerable range. Because BSA reflects extracellular fluid volume more accurately than weight alone, it helps clinicians hit that target more consistently across patients of different sizes.
BSA-based dosing also matters for certain antibiotics and other medications that accumulate in extracellular fluid. The principle is the same: surface area gives a better prediction of how the drug will distribute through the body.
Pediatric Dosing
Children are not simply small adults. Their organ function, metabolism, and body proportions change rapidly with age. Weight-based dosing can over- or undershoot, and age-based dosing ignores the wide size variation among children of the same age. BSA-adjusted dosing provides more consistent drug exposure in children and adolescents compared to adults. Research in pediatric patients aged 1 to 17 found that after adjusting doses by surface area, neither the child’s age nor their specific BSA value significantly influenced how the drug distributed in the body. That consistency is why BSA remains the preferred scaling method for many pediatric medications.
Kidney Function and the 1.73 m² Standard
If you’ve ever had your kidney function tested, the result was likely reported as a glomerular filtration rate (GFR) “normalized” to 1.73 m². That number represents a standardized body surface area, chosen so that kidney function can be compared fairly between people of different sizes.
The 1.73 m² reference dates back to 1928, when researchers calculated it from the average height and weight of 25-year-old American men and women at the time. The logic was straightforward: BSA was considered the closest available proxy for the mass of functioning kidney tissue. That specific value has stuck around for nearly a century, though some researchers have questioned whether it still reflects modern populations, who tend to be taller and heavier than people in the 1920s.
Burn Assessment
BSA takes on a different meaning in burn care. Here, clinicians estimate what percentage of the body’s total surface area has been burned, a figure called TBSA (total body surface area burned). Only partial-thickness and full-thickness burns count toward the calculation, not superficial redness.
The most common tool is the Rule of Nines, which divides the adult body into regions that each represent roughly 9% (or a multiple of 9%) of total surface area:
- Head: 9%
- Each arm: 9%
- Chest: 9%
- Abdomen: 9%
- Upper back: 9%
- Lower back: 9%
- Each leg: 18% (front and back)
- Groin: 1%
The Rule of Nines works well for adults between roughly 10 and 80 kg. For infants and young children, it falls short because their heads are proportionally much larger relative to their bodies. The Lund and Browder chart was designed to handle this, adjusting the percentage assigned to each body region based on the child’s age.
Limitations in People With Obesity
BSA formulas were originally developed using people with body weights that were typical of the early 1900s, well below today’s averages. In people with obesity, the formulas can diverge from one another significantly, and calculated values may not reflect actual surface area. The Du Bois formula, still the most widely used, is known to overestimate BSA by as much as 15% in some individuals compared to direct measurements.
This creates real clinical problems. An overestimated BSA can lead to higher-than-necessary drug doses, increasing the risk of toxicity. It can also distort GFR calculations and cardiac assessments. Clinicians working with patients who have obesity often need to exercise extra judgment, sometimes capping BSA or using adjusted body weight, rather than relying on any single formula.